Correction: Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial.
PubMed 文献 · RMD Open · 2018-09-07
[This corrects the article DOI: 10.1136/rmdopen-2018-000723.].
原文
[This corrects the article DOI: 10.1136/rmdopen-2018-000723.].
来源:RMD Open,查看原文。版权归原作者所有。
引用
- Correction: Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trial. RMD Open. 2018. PMID: 30233814. doi:10.1136/rmdopen-2018-000723corr1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。